MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    A Retrospective Comparison of Multiple Approaches to LFP-guided and Imaging Guided Contact Selection in Subthalamic Deep Brain Stimulation for Parkinson’s Disease

    SH. Herstell, CST. Schedlich-Teufer, ES. Schmehr, JS. Strelow, GB. Brandt, VVV. Visser-Vandewalle, TD. Dembek, MB. Barbe (Cologne, Germany)

    Objective: To retrospectively compare several local field potential (LFP)-guided approaches for contact selection with an imaging-guided strategy and monopolar reviews, using long-term motor outcome as…
  • 2026 International Congress

    α-Synuclein biomarkers in prodromal synucleinopathies: a systematic review and meta-analysis.

    S. Virameteekul, S. Lim, R. Postuma, E. de Pablo-Fernández, A. Noyce (Bangkok, Thailand)

    Objective: To quantify the diagnostic accuracy and predictive performance of α-synuclein biomarkers in isolated REM sleep behaviour disorder (iRBD), pure autonomic failure (PAF), and idiopathic…
  • 2026 International Congress

    Restless leg syndrome in Parkinson’s disease: A systematic review on the prevalence, demographic, clinical profile and diagnostic criteria

    A. Payus, J. Sringean, R. Bhidayasiri (kota kinabalu, Malaysia)

    Objective: This systematic review aims to estimate the pooled prevalence of restless leg syndrome (RLS) in Parkinson’s disease (PD) and illustrate the updated understanding of…
  • 2026 International Congress

    Correlation between handwriting and cognitive function in patients with Parkinson’s disease

    S. Obika, O. Montero, J. Ortega, M. Escribano, A. Ruiz-Yanzi, C. Del Toro, E. Natera-Villalba, C. Gasca-Salas, M. Matarazzo, R. Martínez-Fernández, F. Alonso-Frech (Madrid, Spain)

    Objective: To investigate whether handwriting performance in Parkinson’s disease (PD) patients is associated with neuropsychological function. Background: PD patients typically present impaired handwriting with slower…
  • 2026 International Congress

    GLP-1 Receptor Agonists in Movement Disorders: From Parkinson’s Disease to the Broader Spectrum — Mechanisms, Evidence, and Future Directions

    A. Dahshan (Cairo, Egypt)

    Objective: To provide a comprehensive narrative review of the mechanistic rationale and clinical evidence for GLP-1 RA use across the spectrum of movement disorders, including…
  • 2026 International Congress

    A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson’s disease symptoms

    C. Moreau, F. Marchand, J. Bene, C. Leclercq, V. Foutel, M. Fisichella, D. Devos (Lille, France)

    Objective: To investigate the safety and efficacy of continuous circadian and personalized intracerebroventricular (i.c.v.) administration of anaerobic dopamine (A-dopamine) in Parkinson's disease patients refractory to…
  • 2026 International Congress

    The Spectrum of Praxis Impairments in Patients with Parkinson’s Disease

    Z. Zalyalova, S. Munasipova, A. Volkova (Kazan, Russian Federation)

    Objective: Our study aims to examine the state of praxis within the structure of motor impairments in patients with Parkinson's disease (PD). Background: PD is…
  • 2026 International Congress

    STEM-PD: An open-label phase I/II trial of transplanted human pluripotent stem cell-derived dopaminergic progenitor cells in Parkinson’s disease

    G. Paul, H. Bjartmarz, A. Kirkeby, J. Nelander, R. Smith, S. Kayhanian, A. Evans, B. Harry, E. Cutting, S. Fazal, N. Lao-Kaim, T. van Vliet, I. Grubor, O. Hansson, P. Picchini, O. Lindvall, A. Björklund, H. Widner, M. Parmar, R. Barker (Lund, Sweden)

    Objective: The STEM-PD trial evaluates safety, tolerability, and feasibility of intraputaminal transplantation of STEM-PD, a dopaminergic(DA) progenitor product derived from a clinical-grade human embryonic stem…
  • 2026 International Congress

    Clinical-Genealogical Analysis of Parkinson’s Disease

    M. Ibodullaeva, R. Matmurodov, KH. Daminova (Tashkent, Uzbekistan)

    Objective: The aim of the study is to investigate the clinical and genealogical features of Parkinson's disease. Background: More than 90% of Parkinson's disease (PD)…
  • 2026 International Congress

    PEST-PD: Preliminary Findings from an Ongoing Longitudinal Observational Study for Prodromal Parkinson’s disease in farmers exposed to pesticides.

    E. Cubo, L. Gomez-Cuadrado, D. Garcia-Garcia, A. Canepa, B. Alonzo-Nuñez, D. de Lara (Burgos, Spain)

    Objective: To compare the risk for prodromal Parkinson's disease (PD) in subjects exposed and non-exposed to pesticides Background: Farmers may have an elevated risk of…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley